Aileron Therapeutics, Inc.
Peptidomimetic macrocycles and formulations thereof
Last updated:
Abstract:
Aqueous pharmaceutical formulations, for parenteral administration, comprising peptidomimetic macrocycle or a pharmaceutically acceptable salt thereof wherein the peptidomimetic macrocycle binds to MDM2 and/or MDMX proteins are disclosed. Also disclosed are methods of treating diseases and disorders using the aqueous pharmaceutical formulations disclosed herein.
Status:
Grant
Type:
Utility
Filling date:
24 Sep 2015
Issue date:
2 Feb 2021